FindTrial
Sign In

Clinical trail for the umbilical cord mesenchymal stem cell on the neuropsychiatric systemic lupus erythematosus

Clinical trail for the umbilical cord mesenchymal stem cell on the neuropsychiatric systemic lupus erythematosus

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018883
Enrollment
Unknown
Registered
2018-10-15
Start date
2018-11-01
Completion date
Unknown
Last updated
2018-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neuropsychiatric systemic lupus erythematosus

Interventions

Group 2:Hormone + immunosuppressant + intravenous inject MSCs
Group 1:Hormone + immunosuppressant

Sponsors

Jiangmen Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Aged 16-70years old male or female; (2) Diagnosed as SLE and satisfied the criteria of the NPSLE and excluded the manifestations of nervous system of infection,hypertension and uremia; (3) Patients agree to the therapy of the UC-MSCs and the following examinations and sign the agreement paper.

Exclusion criteria

Exclusion criteria: (1) Infection not under controll; (2) Cadiac function in Grade III-IV; (3) CCr120U/L (5) Repiratory failure; (6) Allergy to blood products; (7) Pregnancy.

Design outcomes

Primary

MeasureTime frame
symptoms of nervous system;MR of head;electroencephalogram;—

Countries

China

Contacts

Public ContactFeng Wei

Department of Rheumatology, Jiangmen Central Hospital

wfrenaldoctor@163.com+86 13702588983

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026